SEQUENT - Viyash Scientific

Viyash Scientific

SEQUENT · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth

4.6%

8.8%

1.5%

4.0%

21.1%

18.4%

0.9%

all

1.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 211 4.6%

188

260

Company Overview

Sales

1,658 Cr

Growth: 10.6%

Profit after Tax

41.8 Cr

Growth: 40.9%

Small Cap

5,352 Cr

P/E: 126.1x

Industry P/E: 30.0x

Fundamentals

Sales (Cr)	₹ 1,658
Growth	10.6%
EBITDA	11.4%
P/S	3.2x
Dividend	0.0%
P/E	126.1x
Book Value	₹ 28.9
PEG Ratio	11.3x
ROE	5.9%
P/B	6.7x

Shareholding Pattern

Institutions

Infinity Holdings

5.91 %

Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii

3.35 %

Ashoka India Opportunities Fund

1.35 %

Sbi Healthcare Opportunities Fund

1.21 %

Mukul Mahavir Agrawal

1.05 %

Promoters

Ca Harbor Investments

53.02 %

Chayadeep Ventures Llp

0.27 %

Rajitha Gopalakrishnan

0.2 %

Sajitha Pillai

0.15 %

Vineetha Mohanakumar Pillai

0.12 %

Others

Increase Decrease No change

Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.

Belongs to (11 Indices) view more

Investors (91)

sequent....

dilip.sh...

harish.n...

Followers (7)

jose4

joy2

ratnesh2